Title Blood and marrow transplantation long term management : survivorship after transplant / edited by Bipin N. Savani, André Tichelli

Edition Second edition

Published Hoboken, NJ : John Wiley & Sons, Inc., 2021

©2021

Click on the following:

ProQuest Ebook Central

Copies

Description 1 online resource (xii, 452 pages) : illustrations (chiefly color), color map

Contents List of contributors Section 1 Late effects concepts 1 Introduction Bipin N Savani and Andre Tichelli 2 International Blood and Marrow registries -- trends on long-term data collection Rachel Phelan, Jakob Passweg, Helen Baldomero, Minako Iida, Yoshiko Atsuta, Shinichiro Okamoto, Mahmoud Aljurf, Feras Alfraih, and Bronwen Shaw 3 Long-term transplant clinic setup André Tichelli, Bipin Savani, Shahrukh K Hashmi, Navneet S Majhail, and Alicia Rovó 4 Telemedicine in patient care of long-term survivors Catherine Lee, Mihkaila Wickline, and Mary Flowers 5 Long-term follow-up calendar André Tichelli, Bipin N Savani, Shahrukh K Hashmi, Navneet S Majhail, and Alicia Rovó 6 Late effects after allogeneic hematopoietic stem cell transplantation Shahrukh Hashmi and Yoshihiro Inamoto 7 Late effects after autologous hematopoietic stem cell transplantation Rajshekhar Chakraborty and Betty Hamilton 8 Long-term follow-up of children Paul Carpenter 9 Graft-versus-host disease and GvHD-associated late effects David Michonneau, Aurélien Sutra-del-Galy, and Gérard Socié 10 Screening and prevention guidelines for hematopoietic cell transplant survivors Neel S Batt, J Douglas Rizzo, and Navneet S Majhail 11 Biology of survivorship after BMT Smita Bhatia Section 2 Specific late effects 12 Secondary malignancies Aurélien Sutra-del-Galy, David Michonneau, and Gérard Socié 13 Anti-infective prophylaxis, immunization and prevention of late infectious complications Per Ljungman 14 Seasonal virus infections in recipients and exposure to family members Nosha Farhadfar, Zeina Al-Mansour, and John Wingard 15 Monitoring and management of hepatitis B, C, and HIV infection before and after transplantation Enric Carreras and Montserrat Rovira 16 Skin chronic graft-versus-host disease Attilio Oliveri and Andrea Bacigalupo 17 Ocular complications Alicia Rovó, André Tichelli, and Yoshihiro Inamoto 18 Oral and dental complications Hildegard Greinix 19 Thyroid late complications Juliana Matthews, Leslee Matheny, and Shubhada Jagasia 20 Pre-transplant considerations in gender, reproductive, and sexual health Dana Shanis, Jeanne Murphy, Kate Debiec, Betty K Hamilton, Shawna Boyle, and Pamela Stratton 21 Post-transplant considerations in gender, reproductive, and sexual health Jeanne Murphy, Dana Shanis, Kate Debiec, Betty K Hamilton, Shawna Boyle, and Pamela Stratton 22 Fertility issues, fertility preservation, and pregnancy outcome in long-term survivors Alicia Rovó, Alison W Loren, André Tichelli, and Nina Salooja 23 Sexual dysfunction in long-term survivors Rebecca Hunter, Sarah Thilges, Janna Gordon, Kristy Luke, Karla Cavazos, Emilee Moeke, Colleen Bruen, and Sunita Natha 24 Non-infectious pulmonary late complications Ayman O Soubani 25 Cardiac and arterial complications Alicia Rovó and André Tichelli 26 Cardiovascular risk factors Kimberley Doucette and Minoo Battiwalla 27 Gastrointestinal complications Sumona Bhattacharya, Steven Pavletic and Theo Heller 28 Hepatic complications Christy Ann L Gilman Christopher Koh, Steven Pavletic, and Theo Heller 29 Renal complications Insara Jaffer Sathick, and Sangeeta Hingorani 30 Post-Transplantation Bone Disease Christine Ducan 31 Neurological late complications Enrico Maffini 32 Neurogognitive dysfunction David Buchbinder 33 Psychological distress Anna Barata, Aasha I Hoogland and Heather SL Jim 34 Persistent chronic fatigue Sandy Mitchell 35 Social issues Sanghee Hong and Navneet Majhail 36 Health-related quality of life in adult and pediatric survivors Lori Wiener, Jenny Hoag, and Tamryn Gray Section 3 Supportive care and patients reported outcome 37 Immunosuppressive agents and monitoring in long-term survivors Katie Culos and Katie Gatwood 38 Nutritional support and nutritional supplementation Shigeo Fuji 39 Daily routines and healthy lifestyle guidelines Melissa Logue 40 Prevalent psychosocial adjustment issues and solutions: lifestyle and social challenges Katrina Stokes 41 Complementary and alternative medicine in HSCT Ibrahim N Muhsen, Bipin N Savani, and Shahrukh Hashmi 42 Impact of adherence in outcome of long-term survivors Corien Eeltink and Annika Kisch 43 Prominent role of allied health professionals Catherine E Lucid 44 Patient reported outcome Hélène Schoemans 45 Caregivers of long-term survivors Angela Moreschi Woods 46 Patient's perspective: memory of a recovered lymphomaniac Michael Brown Appendix 1 Commonly used transplant-related medications in long-term survivors Katie Culos and Katie Gatwood Appendix 2 The eGVHD App Hélène Schoemans Index

Summary "Hematopoietic cell transplantation (HCT) provides curative therapy for a variety of diseases. Over the past several decades, significant advances have been made in the field of HCT and now HCT has become an integral part of treatment modality for a variety of hematologic malignancies and some nonmalignant diseases. HCT remains an important treatment option for a wide variety of hematologic and nonhematologic disorders, despite recent advances in the field of immunologic therapies. Factors driving this growth include expanded disease indications, greater donor options (expanding unrelated donor registries and haploidentical HCT), and accommodation of older and less fit recipients. The development of less toxic pretransplant conditioning regimens, more effective prophylaxis of graft-versus-host disease (GVHD), improved infection control, and other advances in transplant technology have resulted in a rapidly growing number of transplant recipients surviving long-term free of the disease for which they were transplanted. The changes over decades in the transplant recipient population and in the practice of HCT will have almost inevitably altered the composition of the long-term survivor population over time. Apart from an increasingly older transplant recipient cohort, the pattern of transplant indications has shifted from the 1990s when chronic myeloid leukemia made up a significant proportion of allo-HCT indications. Changes in cell source, donor types, conditioning regimens, GVHD prophylaxis, and supportive care have all occurred, with ongoing reductions in both relapse and non-relapse mortality (NRM) have been demonstrated"-- Provided by publisher

Bibliography Includes bibliographical references and index

Notes Description based on online resource; title from digital title page (viewed on April 29, 2022)

Subject Bone marrow -- Transplantation.

Hematopoietic stem cells -- Transplantation

Victims.

Hematopoietic Stem Cell Transplantation -- adverse effects

Long Term Adverse Effects -- prevention & control

Disease-Free Survival

Survivors

Bone Marrow Transplantation

Victims

Bone marrow -- Transplantation

Hematopoietic stem cells -- Transplantation

Form Electronic book

Author Savani, Bipin N., editor.

Tichelli, André, editor.

LC no. 2020053133

ISBN 9781119612780

1119612780

9781119612735

111961273X

9781119612742

1119612748

Permalink

190 results found. Sorted by relevance | date | title .